Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Forst T, Pfützner A, Lübben G, Weber M, Marx N, Karagiannis E, Koehler C, Baurecht W, Hohberg C, Hanefeld M. Forst T, et al. Among authors: hanefeld m. Metabolism. 2007 Apr;56(4):491-6. doi: 10.1016/j.metabol.2006.11.007. Metabolism. 2007. PMID: 17379006 Clinical Trial.
Review of approved pioglitazone combinations for type 2 diabetes.
Forst T, Hanefeld M, Pfützner A. Forst T, et al. Among authors: hanefeld m. Expert Opin Pharmacother. 2011 Jul;12(10):1571-84. doi: 10.1517/14656566.2011.567266. Epub 2011 Jun 4. Expert Opin Pharmacother. 2011. PMID: 21639813 Review.
Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.
Pfützner A, Hanefeld M, Dekordi LA, Müller J, Kleine I, Fuchs W, Forst T. Pfützner A, et al. Among authors: hanefeld m. J Diabetes Sci Technol. 2011 Jul 1;5(4):989-98. doi: 10.1177/193229681100500422. J Diabetes Sci Technol. 2011. PMID: 21880242 Free PMC article. Clinical Trial.
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.
Leonhardt W, Pfützner A, Müller J, Pietzsch J, Forst T, Karagiannis E, Lübben G, Hanefeld M. Leonhardt W, et al. Among authors: hanefeld m. Atherosclerosis. 2008 Nov;201(1):155-62. doi: 10.1016/j.atherosclerosis.2008.01.007. Epub 2008 Apr 18. Atherosclerosis. 2008. PMID: 18374336 Clinical Trial.
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.
Hanefeld M, Pfützner A, Forst T, Kleine I, Fuchs W. Hanefeld M, et al. Cardiovasc Diabetol. 2011 Jul 14;10:65. doi: 10.1186/1475-2840-10-65. Cardiovasc Diabetol. 2011. PMID: 21756323 Free PMC article. Clinical Trial.
399 results